Catalyst Pharmaceuticals
CPRX
#4019
Rank
C$4.06 B
Marketcap
C$33.08
Share price
-1.14%
Change (1 day)
-0.37%
Change (1 year)

Market capitalization of Catalyst Pharmaceuticals (CPRX)

Market cap: C$4.06 Billion

As of February 2026 Catalyst Pharmaceuticals has a market cap of C$4.06 Billion. This makes Catalyst Pharmaceuticals the world's 4019th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalyst Pharmaceuticals from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026C$4.06 B-0.8%
2025C$4.09 B11.54%
2024C$3.67 B54.59%
2023C$2.37 B-9.51%
2022C$2.62 B195.59%
2021C$0.88 B101.05%
2020C$0.44 B-12.72%
2019C$0.50 B88.46%
2018C$0.26 B-46.66%
2017C$0.50 B330.66%
2016C$0.11 B-58.46%
2015C$0.28 B18.2%
2014C$0.23 B112.01%
2013C$0.11 B527.15%
2012C$17.91 M-44.72%
2011C$32.41 M68.88%
2010C$19.19 M60.51%
2009C$11.95 M-61.14%
2008C$30.77 M-28.63%
2007C$43.11 M-38.74%
2006C$70.38 M

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Catalyst Pharmaceuticals was reported to be:

C$4.06 Billion
by Nasdaq info icon info icon
C$4.06 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
C$745.32 B 18,231.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$204.64 B 4,933.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$258.96 B 6,269.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$2.90 B-28.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
C$1.11 M-99.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$14.78 B 263.68%๐Ÿ‡บ๐Ÿ‡ธ USA